geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Clinical outcome of Turkish metastatic breast cancer patients with currently available treatment modalities--single center experience


, : Clinical outcome of Turkish metastatic breast cancer patients with currently available treatment modalities--single center experience. Asian Pacific Journal of Cancer Prevention 15(1): 117-122

Breast cancer is the most common malignancy and the second leading cause of cancer-related death among women in the developed countries. Despite advances in screening, improved local therapies and adjuvant systemic treatments, median survival of metastatic breast cancer patients (MBC) is in the range of 2-3 years at most. We aimed to investigate whether the prognostic factors and therapeutic responses of our Turkish patients are similar to those in the literature. We reviewed the medical records of MBC patients who had been treated in our institution between 1999-2009 and analyzed their clinicopathological features and survival outcomes retrospectively. A hundred and sixty patients were included. Median age was 47 (23-82), median follow up was 24 (2-186) months. At the time of diagnosis 59% of patients were under the age of 50 and 46% were postmenopausal. The majority (37%) had multiple sites of metastases. Forty percent received endocrine therapy and 40% chemotherapy as first line metastatic treatment. Thirty (20%) patients were treated with molecular targeting agents like trastuzumab, lapatinib and sunitinib, frequently combined with a chemotherapy agent. Five-year overall survival (OS) was 32% and median OS was 38 months for the whole group. Five year progression free survival (PFS) was 10% and median PFS was 10 months. Menopausal status, hormone receptor expression and disease free status had a significant impact on overall survival in the multivariate analysis (p 0.018, p 0.018 and p:0.003, respectively). All our patients were treated with the modern oncologic therapies recommended by the international guidelines. From our data, MBC patients live up to 3-4 years, indicating that further improvement beyond that requires development of new treatment modalities. The survival outcomes of our patients were consistent with the data reported in the literature.

US$29.90

PMID: 24528011


Other references

Han, Z.G.; Jiang, W.G.; Hallett, M.B.; Isoai, A.; Mansel, R.E., 1995: Inhibition of dissociation and motility by invasion inhibiting factor 2 on human lung cancer cells. Anticancer Research 15(5A): 1679

Heinrich, R.; Jacobs, K.; Lakes Harlan, R., 1998: Tracing of a neuronal network in the locust by pressure injection of markers into a synaptic neuropil. Central neuronal circuits of vertebrates have often been investigated using injection of markers into synaptic neuropils, whereas similar techniques have rarely been applied in invertebrates. In this study we tested several neuroanatomical tracers...

Zinman, B.; Hanley, A.J.G.; Mckeown Eyssen, G.E.; Harris, S.B.; Wolever, T.M.S., 2000: Proinsulin and cardiovascular disease risk factors in a native Canadian population. Diabetes Research & Clinical Practice 50(Suppl 1): S291, September

Fristrup, N.; Birkenkamp-Demtröder, K.; Reinert, T.; Sanchez-Carbayo, M.; Segersten, U.; Malmström, P-Uno.; Palou, J.; Alvarez-Múgica, M.; Pan, C-Chen.; Ulhøi, B.P.; Borre, M.; Ørntoft, T.F.; Dyrskjøt, L., 2013: Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer. Transcripts from the four genes encoding cyclin D1, MCM7, TRIM29, and UBE2C have previously been included in gene expression signatures for outcome prediction in stage Ta/T1 urothelial carcinomas. We investigated the prognostic value of the protei...

Peters, J.H.; Hausen, P., 1971: Effect of phytohemagglutinin on lymphocyte membrane transport. 2. Stimulation of "facilitated diffusion" of 3-O-methyl-glucose. European Journal of Biochemistry 19(4): 509-513

Kristensen, S.Gry.; Ebbesen, P.; Andersen, C.Yding., 2015: Transcriptional profiling of five isolated size-matched stages of human preantral follicles. Little is known of the early stages of human follicular development and the complex processes that regulate follicular growth. To identify genes of potential importance, we analysed follicle-related transcripts in five populations of isolated size...

Paz-Ríos, C.E.; Ardisson, P-Luis., 2014: Dulichiella celestun, a new species of amphipod (Crustacea: Amphipoda: Melitidae) from the Gulf of Mexico, with a key and zoogeographic remarks for the genus in the western Atlantic. The discovery of a new melitid amphipod in the Celestun Biosphere Reserve (northern Yucatan peninsula, SE Gulf of Mexico) is reported. Dulichiella celestun sp. nov. differs from its congeners by an unique set of characteristics: truncated lateral...

Wamsley, M.A.; Julian, K.A.; Wipf, J.E., 2004: A literature review of "resident-as-teacher" curricula: do teaching courses make a difference?. To examine the evaluation methods of resident teaching courses and to estimate the effectiveness of these teaching courses. We searched the literature from 1975 to May 2003 using the PubMed MESH terms internship and residency and teaching; 1,436 a...

Diacin, M.J.; Parks, J.B.; Allison, P.C., 2003: Voices of male athletes on drug use, drug testing, and the existing order in intercollegiate athletics. This study examines the attitudes of intercollegiate athletes toward drug use and drug testing. Data were collected through semistructured, individual interviews with 8 National Collegiate Athletic Association Division I and Division III male athl...

Nikolov, B., 1970: Effect of lactation period on size and milking ability of udders in South Bulgarian Brown heifers. The rate of size decrease of the udders was highest at the 120th day of lactation. The optimum values of the milking ability index were obtained between the 60th and 150th days of lactation.